Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Bevacizumab Monotherapy in Advanced Cervical Cancer
jRCT2080222700Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in Cervical Cancer (CC), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCT2080222700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222700.